Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Skrondal, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skrondal, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Am J Epidemiol 2003; 158:251-258.
Copyright © 2003 by Johns Hopkins Bloomberg School of Public Health


ORIGINAL CONTRIBUTIONS

Interaction as Departure from Additivity in Case-Control Studies: A Cautionary Note

Anders Skrondal 

From the Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway.

It has been argued that assessment of interaction should be based on departures from additive rates or risks. The corresponding fundamental interaction parameter cannot generally be estimated from case-control studies. Thus, surrogate measures of interaction based on relative risks from logistic models have been proposed, such as the relative excess risk due to interaction (RERI), the attributable proportion due to interaction (AP), and the synergy index (S). In practice, it is usually necessary to include covariates such as age and gender to control for confounding. The author uncovers two problems associated with surrogate interaction measures in this case: First, RERI and AP vary across strata defined by the covariates, whereas the fundamental interaction parameter is unvarying. S does not vary across strata, which suggests that it is the measure of choice. Second, a misspecification problem implies that measures based on logistic regression only approximate the true measures. This problem can be rectified by using a linear odds model, which also enables investigators to test whether the fundamental interaction parameter is zero. A simulation study reveals that coverage is much improved by using the linear odds model, but bias may be a concern regardless of whether logistic regression or the linear odds model is used.

additivity; case-control studies; epidemiologic methods; interaction

Abbreviations: Abbreviations: AP, attributable proportion due to interaction; RERI, relative excess risk due to interaction; S, synergy index.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
R. de Mutsert, D. C. Grootendorst, J. Axelsson, E. W. Boeschoten, R. T. Krediet, F. W. Dekker, and the NECOSAD Study Group
Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2957 - 2964.
[Abstract] [Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
S. Wamala, J. Merlo, G. Bostrom, and C. Hogstedt
Perceived discrimination, socioeconomic disadvantage and refraining from seeking medical treatment in Sweden
J. Epidemiol. Community Health, May 1, 2007; 61(5): 409 - 415.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
D. A. Schaumberg, S. E. Hankinson, Q. Guo, E. Rimm, and D. J. Hunter
A Prospective Study of 2 Major Age-Related Macular Degeneration Susceptibility Alleles and Interactions With Modifiable Risk Factors
Arch Ophthalmol, January 1, 2007; 125(1): 55 - 62.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. Cushman, L. H. Kuller, R. Prentice, R. J. Rodabough, B. M. Psaty, R. S. Stafford, S. Sidney, F. R. Rosendaal, and for the Women's Health Initiative Investigators
Estrogen Plus Progestin and Risk of Venous Thrombosis
JAMA, October 6, 2004; 292(13): 1573 - 1580.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.